Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov.
Identifieur interne : 000705 ( Main/Exploration ); précédent : 000704; suivant : 000706Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov.
Auteurs : Krishna Pundi [États-Unis] ; Alexander C. Perino [États-Unis] ; Robert A. Harrington [États-Unis] ; Harlan M. Krumholz [États-Unis] ; Mintu P. Turakhia [États-Unis]Source :
- JAMA internal medicine [ 2168-6114 ] ; 2020.
Descripteurs français
- KwdFr :
- Betacoronavirus (MeSH), Enregistrements (MeSH), Essais cliniques comme sujet (MeSH), Exactitude des données (MeSH), Humains (MeSH), Infections à coronavirus (prévention et contrôle), Infections à coronavirus (thérapie), Infections à coronavirus (épidémiologie), Médecine factuelle (méthodes), Médecine factuelle (normes), Pandémies (prévention et contrôle), Plan de recherche (normes), Plan de recherche (statistiques et données numériques), Pneumopathie virale (prévention et contrôle), Pneumopathie virale (thérapie), Pneumopathie virale (épidémiologie), Études transversales (MeSH), Évaluation des besoins (MeSH).
- MESH :
- méthodes : Médecine factuelle.
- normes : Médecine factuelle, Plan de recherche.
- prévention et contrôle : Infections à coronavirus, Pandémies, Pneumopathie virale.
- statistiques et données numériques : Plan de recherche.
- thérapie : Infections à coronavirus, Pneumopathie virale.
- épidémiologie : Infections à coronavirus, Pneumopathie virale.
- Betacoronavirus, Enregistrements, Essais cliniques comme sujet, Exactitude des données, Humains, Études transversales, Évaluation des besoins.
English descriptors
- KwdEn :
- Betacoronavirus (MeSH), COVID-19 (MeSH), Clinical Trials as Topic (MeSH), Coronavirus Infections (epidemiology), Coronavirus Infections (prevention & control), Coronavirus Infections (therapy), Cross-Sectional Studies (MeSH), Data Accuracy (MeSH), Evidence-Based Medicine (methods), Evidence-Based Medicine (standards), Humans (MeSH), Needs Assessment (MeSH), Outcome Assessment, Health Care (methods), Outcome Assessment, Health Care (standards), Pandemics (prevention & control), Pneumonia, Viral (epidemiology), Pneumonia, Viral (prevention & control), Pneumonia, Viral (therapy), Registries (MeSH), Research Design (standards), Research Design (statistics & numerical data), SARS-CoV-2 (MeSH).
- MESH :
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- methods : Evidence-Based Medicine, Outcome Assessment, Health Care.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- standards : Evidence-Based Medicine, Outcome Assessment, Health Care, Research Design.
- statistics & numerical data : Research Design.
- therapy : Coronavirus Infections, Pneumonia, Viral.
- Betacoronavirus, COVID-19, Clinical Trials as Topic, Cross-Sectional Studies, Data Accuracy, Humans, Needs Assessment, Registries, SARS-CoV-2.
DOI: 10.1001/jamainternmed.2020.2904
PubMed: 32730617
PubMed Central: PMC7385669
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov.</title><author><name sortKey="Pundi, Krishna" sort="Pundi, Krishna" uniqKey="Pundi K" first="Krishna" last="Pundi">Krishna Pundi</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Medicine, Stanford University School of Medicine, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Perino, Alexander C" sort="Perino, Alexander C" uniqKey="Perino A" first="Alexander C" last="Perino">Alexander C. Perino</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Medicine, Stanford University School of Medicine, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Harrington, Robert A" sort="Harrington, Robert A" uniqKey="Harrington R" first="Robert A" last="Harrington">Robert A. Harrington</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Medicine, Stanford University School of Medicine, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Krumholz, Harlan M" sort="Krumholz, Harlan M" uniqKey="Krumholz H" first="Harlan M" last="Krumholz">Harlan M. Krumholz</name><affiliation wicri:level="2"><nlm:affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Connecticut</region></placeName><wicri:cityArea>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven</wicri:cityArea></affiliation></author><author><name sortKey="Turakhia, Mintu P" sort="Turakhia, Mintu P" uniqKey="Turakhia M" first="Mintu P" last="Turakhia">Mintu P. Turakhia</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Medicine, Stanford University School of Medicine, Stanford</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32730617</idno><idno type="pmid">32730617</idno><idno type="doi">10.1001/jamainternmed.2020.2904</idno><idno type="pmc">PMC7385669</idno><idno type="wicri:Area/Main/Corpus">000461</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000461</idno><idno type="wicri:Area/Main/Curation">000461</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000461</idno><idno type="wicri:Area/Main/Exploration">000461</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov.</title><author><name sortKey="Pundi, Krishna" sort="Pundi, Krishna" uniqKey="Pundi K" first="Krishna" last="Pundi">Krishna Pundi</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Medicine, Stanford University School of Medicine, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Perino, Alexander C" sort="Perino, Alexander C" uniqKey="Perino A" first="Alexander C" last="Perino">Alexander C. Perino</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Medicine, Stanford University School of Medicine, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Harrington, Robert A" sort="Harrington, Robert A" uniqKey="Harrington R" first="Robert A" last="Harrington">Robert A. Harrington</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Medicine, Stanford University School of Medicine, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Krumholz, Harlan M" sort="Krumholz, Harlan M" uniqKey="Krumholz H" first="Harlan M" last="Krumholz">Harlan M. Krumholz</name><affiliation wicri:level="2"><nlm:affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Connecticut</region></placeName><wicri:cityArea>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven</wicri:cityArea></affiliation></author><author><name sortKey="Turakhia, Mintu P" sort="Turakhia, Mintu P" uniqKey="Turakhia M" first="Mintu P" last="Turakhia">Mintu P. Turakhia</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Medicine, Stanford University School of Medicine, Stanford</wicri:cityArea></affiliation></author></analytic><series><title level="j">JAMA internal medicine</title><idno type="eISSN">2168-6114</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (MeSH)</term><term>COVID-19 (MeSH)</term><term>Clinical Trials as Topic (MeSH)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (prevention & control)</term><term>Coronavirus Infections (therapy)</term><term>Cross-Sectional Studies (MeSH)</term><term>Data Accuracy (MeSH)</term><term>Evidence-Based Medicine (methods)</term><term>Evidence-Based Medicine (standards)</term><term>Humans (MeSH)</term><term>Needs Assessment (MeSH)</term><term>Outcome Assessment, Health Care (methods)</term><term>Outcome Assessment, Health Care (standards)</term><term>Pandemics (prevention & control)</term><term>Pneumonia, Viral (epidemiology)</term><term>Pneumonia, Viral (prevention & control)</term><term>Pneumonia, Viral (therapy)</term><term>Registries (MeSH)</term><term>Research Design (standards)</term><term>Research Design (statistics & numerical data)</term><term>SARS-CoV-2 (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Betacoronavirus (MeSH)</term><term>Enregistrements (MeSH)</term><term>Essais cliniques comme sujet (MeSH)</term><term>Exactitude des données (MeSH)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (prévention et contrôle)</term><term>Infections à coronavirus (thérapie)</term><term>Infections à coronavirus (épidémiologie)</term><term>Médecine factuelle (méthodes)</term><term>Médecine factuelle (normes)</term><term>Pandémies (prévention et contrôle)</term><term>Plan de recherche (normes)</term><term>Plan de recherche (statistiques et données numériques)</term><term>Pneumopathie virale (prévention et contrôle)</term><term>Pneumopathie virale (thérapie)</term><term>Pneumopathie virale (épidémiologie)</term><term>Études transversales (MeSH)</term><term>Évaluation des besoins (MeSH)</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Evidence-Based Medicine</term><term>Outcome Assessment, Health Care</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Médecine factuelle</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Médecine factuelle</term><term>Plan de recherche</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term><term>Pandemics</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections à coronavirus</term><term>Pandémies</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Evidence-Based Medicine</term><term>Outcome Assessment, Health Care</term><term>Research Design</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Research Design</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Plan de recherche</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>COVID-19</term><term>Clinical Trials as Topic</term><term>Cross-Sectional Studies</term><term>Data Accuracy</term><term>Humans</term><term>Needs Assessment</term><term>Registries</term><term>SARS-CoV-2</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Betacoronavirus</term><term>Enregistrements</term><term>Essais cliniques comme sujet</term><term>Exactitude des données</term><term>Humains</term><term>Études transversales</term><term>Évaluation des besoins</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32730617</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6114</ISSN><JournalIssue CitedMedium="Internet"><Volume>180</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA internal medicine</Title><ISOAbbreviation>JAMA Intern Med</ISOAbbreviation></Journal><ArticleTitle>Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov.</ArticleTitle><Pagination><MedlinePgn>1398-1400</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamainternmed.2020.2904</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pundi</LastName><ForeName>Krishna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perino</LastName><ForeName>Alexander C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrington</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krumholz</LastName><ForeName>Harlan M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turakhia</LastName><ForeName>Mintu P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Intern Med</MedlineTA><NlmUniqueID>101589534</NlmUniqueID><ISSNLinking>2168-6106</ISSNLinking></MedlineJournalInfo><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Intern Med. 2020 Oct 1;180(10):1400-1401</RefSource><PMID Version="1">32716474</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068598" MajorTopicYN="N">Data Accuracy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="Y">Evidence-Based Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020380" MajorTopicYN="N">Needs Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="Y">Outcome Assessment, Health Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="Y">Research Design</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>07</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32730617</ArticleId><ArticleId IdType="pii">2768882</ArticleId><ArticleId IdType="doi">10.1001/jamainternmed.2020.2904</ArticleId><ArticleId IdType="pmc">PMC7385669</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Clin Epidemiol. 2019 Dec;116:106-113</Citation><ArticleIdList><ArticleId IdType="pubmed">31521723</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2020 Jun 16;172(12):819-821</Citation><ArticleIdList><ArticleId IdType="pubmed">32227189</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Apr 18;395(10232):1245-1246</Citation><ArticleIdList><ArticleId IdType="pubmed">32305088</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li><li>Connecticut</li></region></list><tree><country name="États-Unis"><region name="Californie"><name sortKey="Pundi, Krishna" sort="Pundi, Krishna" uniqKey="Pundi K" first="Krishna" last="Pundi">Krishna Pundi</name></region><name sortKey="Harrington, Robert A" sort="Harrington, Robert A" uniqKey="Harrington R" first="Robert A" last="Harrington">Robert A. Harrington</name><name sortKey="Krumholz, Harlan M" sort="Krumholz, Harlan M" uniqKey="Krumholz H" first="Harlan M" last="Krumholz">Harlan M. Krumholz</name><name sortKey="Perino, Alexander C" sort="Perino, Alexander C" uniqKey="Perino A" first="Alexander C" last="Perino">Alexander C. Perino</name><name sortKey="Turakhia, Mintu P" sort="Turakhia, Mintu P" uniqKey="Turakhia M" first="Mintu P" last="Turakhia">Mintu P. Turakhia</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidStanfordV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000705 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000705 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidStanfordV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32730617
|texte= Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32730617" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidStanfordV1
| This area was generated with Dilib version V0.6.38. |  |